The amygdala and Alzheimer's disease: Positron emission tomographic study of the cholinergic system

Annals of the New York Academy of Sciences

Volumn 985, Issue , 2003, Pages 411-419

  Shinotoh, Hitoshi ^a,b   Fukushi, K ^a   Nagatsuka, S ^a,d   Tanaka, N ^a,e   Aotsuka, A ^a,c   Ota, T ^a,f   Namba, H ^a,g   Tanada, S ^a   Irie, T ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Asahi Hospital for Neurological Diseases   (Japan)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d DAIICHI PURE CHEMICALS CO LTD   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f JUNTENDO UNIVERSITY   (Japan)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetylcholine; Acetylcholinesterase; Alzheimer's disease; Amygdala; Positron emission tomography

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BEHAVIOR; CALCULATION; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; COMPARTMENT MODEL; CONDITIONING; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEMORY CONSOLIDATION; MEYNERT BASAL NUCLEUS; MINI MENTAL STATE EXAMINATION; NEOCORTEX; POSITRON EMISSION TOMOGRAPHY;

EID: 0037274177     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07097.x     Document Type: Conference Paper

References (20)

1. FRANCIS, P.T., A.M. PALMER, M. SNAPE, et al. 1999. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 66: 137-147.
2. DAVIES, P. & A.J.F. MALONEY. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403.
3. PERRY, E.K., B.E. TOMLINSON, G. BLESSED, et al. 1978. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2: 1427-1429.
4. BIERER, L.M., V. HAROUTUNIAN, S. GARBRIEL, et al. 1995. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64: 749-760.
5. MESULAM, M.M., E.J. MUFSON, B.H. WAINER, et al. 1983. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10: 1185-1201.
6. EVERITT, B.J. & T.W. ROBBINS. 1997. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48: 649-684.
7. MCGAUGH, J.L., I.B. INTROINI-COLLISON, L.F. CAHILL, et al. 1993. Neuromodulatory systems and memory storage: role of the amygdala. Behav. Brain Res. 58: 81-90.
8. IRIE, T., K. FUKUSHI, H. NAMBA, et al. 1996. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease. J. Nucl. Med. 37: 649-655.
9. NAMBA, H., M. IYO, K. FUKUSHI, et al. 1999. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age. Eur. J. Nucl. Med. 26: 135-143.
10. IYO, M., H. NAMBA, K. FUKUSHI, et al. 1997. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease. Lancet 349: 1805-1809.
11. SHINOTOH, H., H. NAMBA, K. FUKUSHI, et al. 2000. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study. Ann. Neurol. 48: 194-200.
12. SHINOTOH, H., H. NAMBA, M. YAMAGUCHI, et al. 1999. Positron emisstion tomography measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Ann. Neurol. 46: 62-69.
13. SHINOTOH, H., A. AOTSUKA, K. FUKUSHI, et al. 2001. Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET. Neurology 56: 408-410.
14. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34: 939-944.
15. NAGATUSKA, S., H. NAMBA, M. IYO, et al. 1998. Quantiative measurement of acetylcholinesterase activiy in living human brain using a radioactive acetylcholine analog and dynamic PET. In Quantitative Functional Brain Imaging with Positron Emission Tomography. R.E. Carson, M.E. Daube-Whitherspoon & P. Herscovitch, Eds. :393-399. Academic Press. San Diego.
16. 11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography tracer for measurement of acetylcholinesterase activity in human brain. J. Cereb. Blood Flow Metab. 19: 1150-1163.
17. ATACK, J.R., E.K. PERRY, J.R. BONHAM, et al. 1986. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J. Neurochem. 47: 263-277.
18. DAVIES, P. 1979. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 171: 319-327.
19. PERRY, E.K. 1983. The cholinergic system in old age and Alzheimer's disease. Age Ageing 9: 1-8.
20. MESULAM, M.M. 1996. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. In Progress in Brain Research. J. Klein & K. Leffeholz, Eds. Vol. 109: 285-297. Elsevier Science, Amsterdam.